Generics 59

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Dorzolamide manufacturers

59 products found

Filters

59 products found

dorzolamide

Ear/eye/nose drops 20 mg/ml - 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Portugal
Manufacturer #461
A pharmaceutical manufacturer based in the EU that is active in 10+ countries selling its products in Europe, Africa, Asia, and LATAM. The company's key therapeutic areas are ophthalmology, dermatology, otorhinolaryngology, and dermo-cosmetics. Key production lines are medicine, medical devices, cosmetics, body care products, and food supplements with GMP. The company does eCTD dossier preparation.

Manufacturer usually replies in 9 days

dorzolamide + timolol

Ophthalmic solution (4+1) mg/0.2 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #298

Manufacturer usually replies in 5 days

dorzolamide

Eye drops 2 % - 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Comments
Reference product: Trusopt
Manufacturer #417
A pharmaceutical manufacturer based in the EU that has been active in 30+ countries selling its products in Europe, North America, Middle East, CIS, Africa, Oceania, and Asia for 40+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant. Main dosage forms include oral solutions, gels, oral suspensions, and topicals. The company prepares a CTD format dossier.

Manufacturer usually replies in 8 days

dorzolamide + timolol

Eye drops 2% w/v + 0.5% w/v

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17353
It is an ophthalmic drugs company based in England, that was founded in the 2000s. They specialize in product development and licensing to improve ocular health and treat a variety of visual illnesses. They provide ophthalmic drugs to wholesalers in each market. The ophthalmic products are made by carefully selected subcontractors following GMP guidelines.

Manufacturer usually replies in 9 days

dorzolamide

Eye drops 20mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17353
It is an ophthalmic drugs company based in England, that was founded in the 2000s. They specialize in product development and licensing to improve ocular health and treat a variety of visual illnesses. They provide ophthalmic drugs to wholesalers in each market. The ophthalmic products are made by carefully selected subcontractors following GMP guidelines.

Manufacturer usually replies in 9 days

dorzolamide + timolol

Eye drops (20mg+5mg)/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #376
A pharmaceutical manufacturer based in the EU that has been active in EU, CIS, Middle East, North America, and Africa selling its products for 40+ years. Key production lines are Rx and OTC. Main therapeutic areas include cardiology, urology, respiratory system, and oncology. The company's production lines are GMP-compliant. Main dosage forms include solids, semi-solid, liquid, and sterile products.

Manufacturer usually replies in 6 days

dorzolamide

Eye drops 20mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #376
A pharmaceutical manufacturer based in the EU that has been active in EU, CIS, Middle East, North America, and Africa selling its products for 40+ years. Key production lines are Rx and OTC. Main therapeutic areas include cardiology, urology, respiratory system, and oncology. The company's production lines are GMP-compliant. Main dosage forms include solids, semi-solid, liquid, and sterile products.

Manufacturer usually replies in 6 days

dorzolamide

Eye drops 20 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #14918

Manufacturer usually replies in 6 days

dorzolamide

Eye drops 2%

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 3 days

dorzolamide + timolol

Eye drops 20 mg + 5 mg/ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #12923
It is the successor of one of the largest pharmaceutical manufacturers in southeast Europe. To date, it has been present over 60 years of experience in the development, production, and sale of generic drugs for human and veterinary use. It has a pharmaceutical plant with facilities for the production of the following dosage forms: capsules and tablets, liquid sterile and dry injection forms, semi-solid forms, creams, and ointments for skin and eye use. The plant has the necessary production licenses and certificates of GMP for all productions.

Manufacturer usually replies in 9 days

dorzolamide + timolol

Eye drops 2 % + 0.5 % - 10 ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Dossier availability date: Q1 2024 Reference product: Cosopt
Manufacturer #417
A pharmaceutical manufacturer based in the EU that has been active in 30+ countries selling its products in Europe, North America, Middle East, CIS, Africa, Oceania, and Asia for 40+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant. Main dosage forms include oral solutions, gels, oral suspensions, and topicals. The company prepares a CTD format dossier.

Manufacturer usually replies in 8 days

dorzolamide

Eye drops 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply
Manufacturer #8588
It was founded in the early 1990s. It is in South-Eastern Europe. Customer satisfaction is the main priority and provides a wide range of medicines, herbal medicines, and biologically active products. The company is present in a foreign market with more than 20% of the product portfolio.

Manufacturer usually replies in 9 days

dorzolamide + timolol

Eye drops 20 mg/ml + 5 mg/ml - 5 ml, 0.16 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Comments
Multidose preservative-free - under development
Manufacturer #6580
A pharmaceutical manufacturer based in the EU that has been active in 20+ countries selling its products in Europe, MENA, LATAM, Asia, and NA for 20+ years. Key production lines are Rx and medical devices. Main therapeutic areas include oncology and respiratory. The company's production lines are GMP-compliant.

Manufacturer usually replies in 11 days

dorzolamide + timolol

Ophthalmic solution 20 mg/ml + 5 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Manufacturer #17782
Over 40 years ago, it was founded in North America. The company has long been a leader in the generic product manufacturing industry. It has earned a name for itself in the production of branded and over-the-counter private label items. Customers are actively and attentively listened to by the company. They anticipate the evolution of new markets and are ready to adapt to new medical needs.

Manufacturer usually replies in 7 days

dorzolamide + timolol

Eye drops 2%+0.5%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
EU GMP
Manufacturer #11554
It is the leading pharmaceutical company specializing in ophthalmic products. The company has acquired EU GMP certification and has been under preparation for CGMP approval for both manufacturing sites of multi-dose and single-dose products.

Manufacturer usually replies in 6 days

dorzolamide + timolol maleate

Eye drops 2 % + 0.5 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
FDA
Manufacturer #20861

Manufacturer usually replies in 4 days

dorzolamide + timolol

Eye drops 2% + 0.5%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
United Kingdom, FDA
Manufacturer #2612

Manufacturer usually replies in 4 days

dorzolamide

Eye drops 2%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
United Kingdom, FDA
Manufacturer #2612

Manufacturer usually replies in 4 days

dorzolamide + timolol

Ophthalmic solution 2 % + 0.5 % - 10 ml

Dossier type
US CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA
Comments
ANDA / R &D Status: ANDA to be filed in Q3-2023, approval expected Q3-2024; US RLD / Holder: "Cosopt / Oak Pharmaceuticals"; Indication: Carbonic anhydrase inhibitor/ beta-blocker. Indicated in the treatment of elevated intraocular pressure (IOP)
Manufacturer #8216

Manufacturer usually replies in 6 days

dorzolamide + timolol

Eye drops 20 mg + 5 mg / ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
EU GMP, PICS
Manufacturer #18087
It is one of the leading specialty pharmaceutical companies. The company specializes in ophthalmology, an image contrast agent (MRI and CT), and gastrointestinal products. It is an FDA and EU-GMP-approved manufacturer exporting ophthalmic products to U.S., EU, and Asia.

Manufacturer usually replies in 10 days

Want to view all 59 products? Create your free account today!

Dorzolamide Manufacturers

Dorzolamide is mainly used for treating high pressure inside the eye due to open angle-type (glaucoma) or other eye conditions (such as ocular hypertension). Reducing high pressure inside the eye enables to prevent of blindness. Warnings: Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking Dorzolamide: You should not use this medical drug if you are allergic to it This drug may also be used for purposes that may not have been listed in this medication guide. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Dorzolamide manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical platform for sales.

How does Dorzolamide work?

The usage of this pharmaceutical substance: Read the Guide and, if available, the Patient Information Leaflet that will be provided by your pharmacist before you start taking Dorzolamide. If you have any questions related to this medical remedy, ask your pharmacist or health care professional. This pharmaceutical product is for use in the eye(s), normally one drop in the affected eye(s) 3 times every day, or as instructed by your health care professional.

The Wholesale Price of Dorzolamide?

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the price. The exact wholesale price of Dorzolamide is around $14.21. Prices of this pharmaceutical substance may change depending on the pharmacy you visit.

Sourcing the Dorzolamide Manufacturers and Suppliers

If you are looking to find Dorzolamide manufacturers and Dorzolamide suppliers, locate them quickly using Pipelinepharma's online marketplace. With this convenient B2B platform, you can order types of medications and quantities you require from companies that have passed our stringent vetting and quality control procedures. Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Dorzolamide offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and these substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of this pharmaceutical product. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Dorzolamide is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Dorzolamide manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.